Shop

Author at Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Press Releases

24 May 2024

8 Above and award-winning filmmaker Jon Reiss announce the launch of the groundbreaking podcast Plantscendence

8 Above and award-winning filmmaker and author Jon Reiss announced the launch of the groundbreaking podcast Plantscendence. Join Reiss on a transformative journey as he explores the world of psychedelics...

By Microdose

Events

21 Nov 2023

Wonderland 2023 Review: PsychMD

With Wonderland 2023 still fresh in our rear-view mirrors, let’s take a moment to look at some of the highlights from the big event....

By Microdose

Culture

6 Nov 2023

Wonderland and Kandyflip.Art Present Art Auction Featuring Rare Graffiti Art From Renowned Artists

Wonderland and Kandyflip.Art Present Art Auction Featuring Rare Graffiti Art From Renowned Artists...

By Microdose

Events

2 Nov 2023

Microdose Announces Dr. Sam Clark, CEO of Terran Biosciences, as Wonderland 2023 Keynote Presenter

In addition to presenting a Keynote address, Dr. Clark will lead a workshop and speak on two panels:at Wonderland 2023....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Culture

17 Oct 2023

Honoring Roland Griffiths: Psychedelic Pioneer

The psychedelic medicine community has lost one of its great figures as Dr. Roland Griffiths has passed away....

By Microdose

Industry

13 Sep 2023

The Longevity+DeSci Summit: Advancing the Frontiers of Longevity Science

The Microdose team attended the Longevity+DeSci Summit NYC, held on August 10-11, 2023. This groundbreaking conference brought together leaders in aging research, biotechnology, and decentralized science. Organized by the nonprofit...

By Microdose

Culture

6 Sep 2023

Ethical Concerns in Psychedelic Therapy

A deeper look at some of the ethical concerns in the psychedelic medicine space and how to best address them....

By Microdose

Health & Wellness

30 Aug 2023

Psychedelic Navigators: The Crucial Role of Guides and Therapists

Psychedelics can be powerful tools for healing. But as they say in the comics, with great power comes great responsibility. Which is why psychedelic practitioners — guides and therapists —...

By Microdose

Industry

28 Aug 2023

Using Virtual Reality for Innovation and Safer Psychedelic Experiences

VR can be used to help prepare for psychedelic therapy, guide them through the journey, and help them integrate experiences....

By Microdose

Follow us on social

Latest News

Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing

The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine

Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments

You Might Also Like

11 Aug 2026

Enveric Biosciences Adds Another Data Point to Its Case That EB-003 Won’t Get You High

Enveric Biosciences is trying to answer one of the trickiest questions in the psychedelic drug space: can you get the antidepressant benefits people associate with psychedelics without the trip? On...

By Madison Roberts

28 Jul 2026

FDA’s New Psychedelic Guidance Signals a Maturing Industry. Now Comes the Hard Part.

For years, the psychedelic medicine industry has operated in largely uncharted regulatory territory. Companies developing psilocybin, LSD, MDMA, and next-generation psychedelic-inspired compounds have often found themselves navigating a clinical landscape...

By Madison Roberts

13 Jul 2026

The Psychedelic Sector Has Grown Up. Wall Street Just Hasn’t Fully Realized It Yet

The sector experienced an early wave of enthusiasm fueled by bold promises, lofty valuations, and the belief that psychedelic medicine would quickly transform mental healthcare. Reality, however, proved more complicated....

By Madison Roberts

28 May 2026

Medical Psilocybin Act

New York lawmakers are officially considering the “Medical Psilocybin Act,” legislation that would create legal access to psilocybin therapy for conditions like PTSD, treatment-resistant depression, substance use disorders, end-of-life distress,...

By Madison Roberts

5 May 2026

PTSD, Policy Shifts, and the Rise of Neuroplastogens: What Enveric’s Latest Data Signals for the Field

By Madison Roberts

21 Apr 2026

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

President Donald Trump’s April 2026 executive order on accelerating treatments for serious mental illness does something the psychedelic industry has been waiting for, and quietly fearing. It removes ambiguity. For...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.